Specifically, polymyositis demonstrated the capacity to decrease the levels of 2 immune cell types (OR < 1, P < .05): B cell panel: CD28 on secreting CD4 regulatory T cell and myeloid cell panel: CD45 on CD33‐ HLA-DR‐. Here, PTPRC is linked to polymyositis.